Shoulder Innovations grants Andrew Hykes 669 stock units
The reported per-share figure for the restricted stock unit award was $19.60.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Andrew Hykes, a director of Shoulder Innovations, Inc. (SI), acquired 669 restricted stock units on October 5, 2026, in lieu of cash retainer fees. The units were fully vested as of the grant date; each represents a contingent right to one share of common stock and has no expiration date. Hykes elected to defer receipt of the shares issuable upon settlement until his departure from the Board of Directors. His reported direct position after the award was 7,438 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 669 | $19.60 | $13K |
Footnotes (1)
- F1. Represents an award of restricted stock units ("RSUs") received in lieu of cash retainer fees, which were fully vested as of the grant date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. The Reporting Person voluntarily elected to defer receipt of the Common Stock issuable upon settlement of the RSUs until the Reporting Person's departure from the Board of Directors.
Key Figures
Key Terms
restricted stock units financial
contingent right financial
settlement financial
cash retainer fees financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many SI restricted stock units did director Andrew Hykes acquire?
Do Andrew Hykes's SI restricted stock units expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.